| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business &Strat Officer | Senior Vice President
1 company
Delong Mark Jeffrey is a Chief Business &Strat Officer at APLS. Recent filings cover 0 purchases and 26 sales. Those positions are worth an estimated $2.5M at current prices.
Our model assigns Delong Mark Jeffrey a strong insider score of 76/100, based on 25 past trades. Over a 12-month horizon, 91.3% of those trades were profitable, with an average 12-month return of +29.6%.
Delong Mark Jeffrey's largest disclosed position is in APLS as Chief Business &Strat Officer, worth about $2.5M. The recent filings there lean toward selling, a net 81,129 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 368 | $22.15 | $8,152.56 | -0.3% | +84.0% | - | |
| Jan 13, 2026 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 1,780 | $22.19 | $39,493.22 | -2.1% | +91.2% | - | |
| Feb 11, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 363 | $28.54 | $10,359.58 | -0.4% | -38.6% | -21.8% | |
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 365 | $29.52 | $10,776.11 | -0.4% | -38.2% | -21.8% | |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 1,396 | $30.43 | $42,474.00 | -1.6% | -42.8% | -27.6% | |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 1,235 | $29.96 | $36,998.38 | -2.1% | -39.2% | -33.4% | |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 1,599 | $28.70 | $45,894.66 | -2.6% | -32.4% | -25.4% | |
| Mar 18, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 9,913 | $56.90 | $564,049.70 | -15.3% | -28.3% | -56.6% | |
| Feb 12, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 597 | $67.77 | $40,456.84 | -0.9% | -36.5% | -57.9% | |
| Jan 29, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Business &Strat Officer | Sell | 367 | $64.14 | $23,538.72 | -0.6% | -26.8% | -55.2% |